Why the study?
Does fluoxetine 60 mg daily improve weight loss and glycaemic control in obese elderly patients with Type 2 diabetes?
Population
30 obese subjects over 60 years of age with Type 2 diabetes, diet controlled with HbA1 < 14% and BMI > 29…
Comparison
Fluoxetine 60 mg daily for 6 months vs Placebo
Design
RCT, randomized, parallel, double-blind
Follow-up
6 months
Authors
Loading...
Supports adjunctive fluoxetine for short-term weight and glycemic control in obese elderly T2D; extends RCT evidence to this population.
Does fluoxetine 60 mg daily improve weight loss and glycaemic control in obese elderly patients with Type 2 diabetes?
Fluoxetine 60 mg daily aids short-term weight loss and improves glycaemic control in obese elderly patients with Type 2 diabetes.
Connolly et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: